PAPILLARY CARCINOMA
Clinical trials for PAPILLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PAPILLARY CARCINOMA trials appear
Sign up with your email to follow new studies for PAPILLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could Once-Daily radiation replace Twice-Daily for breast cancer recurrence?
Disease control Recruiting nowThis study is for women whose breast cancer has come back after initial breast-conserving surgery and whole breast radiation. The standard treatment after repeat surgery is radiation twice a day for 30 sessions. This trial tests whether giving radiation once a day for 15 sessions…
Matched conditions: PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New Alpha-Particle drug targets Hard-to-Treat thyroid cancer
Disease control Recruiting nowThis early-stage trial tests a new radioactive drug called Af-001 in people with advanced differentiated thyroid cancer that cannot be removed by surgery or has spread. The study has two parts: first, to find the safest dose, and second, to see if multiple doses can shrink tumors…
Matched conditions: PAPILLARY CARCINOMA
Phase: PHASE1 • Sponsor: Alpha Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC